Morning Market Movers By: Benzinga via Benzinga December 12, 2014 at 09:42 AM EST ChemoCentryx (NASDAQ: CCXI) shares jumped 65.70% to $7.44 as primary endpoint achieved in Phase II CCX140 trial. Talisman Energy ... Read More >> Related Stocks: Adobe Systems Chemocentryx Inc China Hgs Real Est Gopro Inc Cl A